Page 91 - Clinical Immunology_ Principles and Practice ( PDFDrive )

76 Part one Principles of Immune Response

REFERENCES 29. Kirkham PM, Schroeder HW Jr. Antibody structure and the evolution of
immunoglobulin V gene segments. Semin Immunol 1994;6(6):347–60.
1. Williams AF, Barclay AN. The immunoglobulin superfamily—domains 30. Kawasaki K, Minoshima S, Nakato E, et al. One-megabase sequence
for cell surface recognition. Ann Rev Immunol 1988;6:381–405. analysis of the human immunoglobulin lambda gene locus. PCR Meth
2. Padlan EA. Anatomy of the antibody molecule. Mol Immunol App 1997;7(3):250–61.
1994;31(3):169–217. 31. Vettermann C, Jack HM. The pre-B cell receptor: turning autoreactivity
3. Sanchez-Mazas A, Fernandez-Vina M, Middleton D, et al. Immunogenetics into self-defense. Trends Immunol 2010;31(5):176–83.
as a tool in anthropological studies. Immunology 2011;133(2):143–64. 32. Matsuda F, Ishii K, Bourvagnet P, et al. The complete nucleotide sequence
4. Ehrenmann F, Kaas Q, Lefranc MP. IMGT/3Dstructure-DB and IMGT/ of the human immunoglobulin heavy chain variable region locus. J Exp
DomainGapAlign: a database and a tool for immunoglobulins or Med 1998;188(11):2151–62.
antibodies, T cell receptors, MHC, IgSF and MhcSF. Nucleic Acids Res 33. Hwang JK, Alt FW, Yeap LS. Related Mechanisms of Antibody Somatic
2010;38(Database issue):D301–7. Hypermutation and Class Switch Recombination. Microbiol Spectr
5. Nelson AL. Antibody fragments: hope and hype. MAbs 2010;2(1):77–83. 2015;3(1):MDNA3-0037-2014.
6. Schroeder HW Jr, Cavacini L. Structure and function of 34. Casellas R, Basu U, Yewdell WT, et al. Mutations, kataegis and
immunoglobulins. J Allergy Clin Immunol 2010;125(2 Suppl. 2):S41–52. translocations in B cells: understanding AID promiscuous activity. Nat
7. Johansen FE, Braathen R, Brandtzaeg P. Role of J chain in secretory Rev Immunol 2016;16(3):164–76.
immunoglobulin formation. Scand J Immunol 2000;52(3):240–8. 35. Tomlinson IM, Cox JP, Gherardi E, et al. The structural repertoire of the
8. Chen FH, Arya SK, Rinfret A, et al. Domain-switched mouse IgM/IgG2b human V kappa domain. EMBO J 1995;14(18):4628–38.
hybrids indicate individual roles for C mu 2, C mu 3, and C mu 4 36. Chothia C, Lesk AM, Gherardi E, et al. Structural repertoire of the
domains in the regulation of the interaction of IgM with complement human VH segments. J Mol Biol 1992;227:799–817.
C1q. J Immunol 1997;159(7):3354–63. 37. Tomlinson IM, Walter G, Jones PT, et al. The imprint of somatic
9. Sensel MG, Kane LM, Morrison SL. Amino acid differences in the hypermutation on the repertoire of human germline V genes. J Mol Biol
N-terminus of C(H)2 influence the relative abilities of IgG2 and IgG3 to 1996;256(5):813–17.
activate complement. Mol Immunol 1997;34(14):1019–29. 38. Khass M, Blackburn T, Burrows PD, et al. A new role for VpreB: an
10. Skvaril F, Schilt U. Characterization of the subclass and light chain types invariant surrogate antigen that selects Ig antigen binding sites. Sci
of IgG antibodies to rubella. Clin Exp Immunol 1984;55:671–6. Immunol 2016;1(1).
11. Barrett DJ, Ayoub EM. IgG2 subclass restriction of antibody to 39. Arden B, Clark SP, Kabelitz D, et al. Human T-cell receptor variable gene
pneumococcal polysaccharides. Clin Exp Immunol 1986;63:127–34. segment families. Immunogenet 1995;42(6):455–500.
12. Otteson EA, Skvaril F, Tripathy SP, et al. Prominence of IgG4 in the IgG 40. Jung D, Giallourakis C, Mostoslavsky R, et al. Mechanism and control of
antibody response to human filiariasis. J Immunol 1985;134:2707–12. V(D)J recombination at the immunoglobulin heavy chain locus. Annu
13. James LK, Till SJ. Potential Mechanisms for IgG4 Inhibition of Immediate Rev Immunol 2006;24:541–70.
Hypersensitivity Reactions. Curr Allergy Asthma Rep 2016;16(3):23. 41. Levin-Klein R, Bergman Y. Epigenetic regulation of monoallelic
14. Martinez-Valle F, Fernandez-Codina A, Pinal-Fernandez I, et al. rearrangement (allelic exclusion) of antigen receptor genes. Front
IgG4-related disease: evidence from six recent cohorts. Autoimmun Rev Immunol 2014;5:625.
2017;16(2):168–72. 42. Nemazee D, Weigert M. Revising B cell receptors. J Exp Med
15. Suzuki K, Ha SA, Tsuji M, et al. Intestinal IgA synthesis: a primitive form 2000;191(11):1813–17.
of adaptive immunity that regulates microbial communities in the gut. 43. Neuberger MS, Patel KJ, Dariavach P, et al. The mouse B-cell antigen
Semin Immunol 2007;19(2):127–35. receptor: definition and assembly of the core receptor of the five
16. Stone KD, Prussin C, Metcalfe DD. IgE, mast cells, basophils, and immunoglobulin isotypes. Immunol Rev 1993;132:147–61.
eosinophils. J Allergy Clin Immunol 2010;125(2 Suppl. 2):S73–80. 44. Wang LD, Clark MR. B-cell antigen-receptor signalling in lymphocyte
17. Davis MM, Bjorkman PJ. T-cell antigen receptor genes and T-cell development. Immunology 2003;110(4):411–20.
recognition. Nature 1988;334:395–402. 45. Pelanda R, Braun U, Hobeika E, et al. B cell progenitors are arrested in
18. Rossjohn J, Gras S, Mile JJ, et al. T cell antigen receptor recognition of maturation but have intact VDJ recombination in the absence of Ig-alpha
antigen-presenting molecules. Annu Rev Immunol 2015;33:169–200. and Ig-beta. J Immunol 2002;169(2):865–72.
19. O’Brien RL, Roark CL, Jin N, et al. γδT-cell receptors: functional 46. Mason DY, Cordell JL, Brown MH, et al. CD79a: a novel marker for
correlations. Immunol Rev 2007;215:77–88. B-cell neoplasms in routinely processed tissue samples. Blood
20. Cohen NR, Garg S, Brenner MB. Antigen Presentation by CD1 Lipids, T 1995;86(4):1453–9.
Cells, and NKT Cells in Microbial Immunity. Adv Immunol 47. Tsuganezawa K, Kiyokawa N, Matsuo Y, et al. Flow cytometric diagnosis
2009;102:1–94. of the cell lineage and developmental stage of acute lymphoblastic
21. Bonneville M, O’Brien RL, Born WK. Gammadelta T cell effector leukemia by novel monoclonal antibodies specific to human pre-B-cell
functions: a blend of innate programming and acquired plasticity. Nat receptor. Blood 1998;92(11):4317–24.
Rev Immunol 2010;10(7):467–78. 48. Gauld SB, Cambier JC. Src-family kinases in B-cell development and
22. Allison TJ, Garboczi DN. Structure of gammadelta T cell receptors and signaling. Oncogene 2004;23(48):8001–6.
their recognition of non-peptide antigens. Mol Immunol 49. Schamel WW, Reth M. Monomeric and oligomeric complexes of the B
2002;38(14):1051–61. cell antigen receptor. Immunity 2000;13(1):5–14.
23. Li H, Llera A, Malchiodi EL, et al. The structural basis of T cell activation 50. Conley ME. Genetics of hypogammaglobulinemia: what do we really
by superantigens. Ann Rev Immunol 1999;17:435–66. know? Curr Opin Immunol 2009;21(5):466–71.
24. Tonegawa S. Somatic generation of antibody diversity. Nature 51. Carroll MC. The role of complement and complement receptors in
1983;302:575–81. induction and regulation of immunity. Ann Rev Immunol
25. Krangel MS. Mechanics of T cell receptor gene rearrangement. Curr Opin 1998;16:545–68.
Immunol 2009;21(2):133–9. 52. Fujimoto M, Poe JC, Inaoki M, et al. CD19 regulates B lymphocyte
26. Roth DB. V(D)J recombination: mechanism, errors, and fidelity. responses to transmembrane signals. Semin Immunol 1998;10(4):267–77.
Microbiol Spectr 2014;2(6). 53. Fearon DT, Carroll MC. Regulation of B lymphocyte responses to foreign
27. Carmona LM, Schatz DG. New insights into the evolutionary origins of and self-antigens by the CD19/CD21 complex. Ann Rev Immunol
the recombination-activating gene proteins and V(D)J recombination. 2000;18:393–422.
FEBS J 2016;doi:10.1111/febs.13990. [Epub ahead of print]. 54. Otero DC, Anzelon AN, Rickert RC. CD19 function in early and late B
28. Zachau HG. The immunoglobulin kappa gene families of human and cell development: I. Maintenance of follicular and marginal zone B cells
mouse: a cottage industry approach. Biol Chem 2000;381(9-10):951–4. requires CD19-dependent survival signals. J Immunol 2003;170(1):73–83.